Bohlin Garen G's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed May 16, 2024
- Accession no.
- 0001062993-24-010536
- Filed
- May 16, 2024
- Trade date
- May 14-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $936.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bohlin Garen GCIK 0001254705 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Common Stock | MOption exerciseAcquired | +28,985 | $5.73 | +$166,084.05 | 73,760 | Direct | |
| May 14, 2024 | Common Stock | SSaleDisposed | −28,985 | $32.30 | −$936,215.5 | 44,775 | Direct | |
| May 16, 2024 | Common Stock | AGrant or awardAcquired | +7,693 | $0.00 | $0 | 52,468 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Common Stock | MOption exerciseDisposed | −28,985 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.